2018
DOI: 10.1016/j.freeradbiomed.2018.03.053
|View full text |Cite
|
Sign up to set email alerts
|

Up-regulation of NOX1/NADPH oxidase following drug-induced myocardial injury promotes cardiac dysfunction and fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
20
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 29 publications
(22 citation statements)
references
References 37 publications
1
20
0
1
Order By: Relevance
“…ROS are well-known for their role in mediating both physiological and pathophysiological signal transduction. In fact, ROS is highly reactive in cardiomyocyte hypertrophy and even in the activation of cardiac fibroblasts 36 . Clinical and experimental studies have provided enough evidences that excess ROS can cause myocardial remodeling, including contractile dysfunction and structural alterations 37 .…”
Section: Discussionmentioning
confidence: 99%
“…ROS are well-known for their role in mediating both physiological and pathophysiological signal transduction. In fact, ROS is highly reactive in cardiomyocyte hypertrophy and even in the activation of cardiac fibroblasts 36 . Clinical and experimental studies have provided enough evidences that excess ROS can cause myocardial remodeling, including contractile dysfunction and structural alterations 37 .…”
Section: Discussionmentioning
confidence: 99%
“…Although fibrosis was previously recognized as an irreversible progress [37], emerging evidence demonstrated that certain circumstances allowed fibrosis resolution when the underlying preventable causes of fibrogenesis were eradicated [38][39][40]. NOX-derived ROS were intimately involved in numerous organ fibrosis such as heart, liver, lung and kidney [41][42][43], particularly for NOX4 in the nephropathic milieu, which was recognized as the most abundant isoforms in renal proximal tubular epithelial cells [29]. A reduction of NOX4 expression by carnosic acid treatment has been proved to protect against unilateral ureteral obstruction-induced renal fibrosis, fueling considerable enthusiasm for NOX4 blockade as an attractive therapy [44].…”
Section: Nox Signalingmentioning
confidence: 99%
“…A, acrolein and MVK dose‐dependently reduced the viability of H9c2 cells. To clarify which NOX isoform(s) is involved in acrolein‐ or MVK‐ induced cytotoxicity, we generated Nox ‐disrupted H9c2 cells by CRISPR–Cas9‐mediated genome editing . Because the expression of NOX2 was marginal in these cells, Nox2 disruption did not affect acrolein‐ or MVK‐induced cytotoxicity (Fig.…”
Section: Resultsmentioning
confidence: 99%